SOMAÍ Pharmaceuticals Acquires RPK Biopharma (Holigen), Reinforcing Global Leading Position in Medicinal Cannabis Sector
SOMAÍ Pharmaceuticals Unipessoal LDA ("SOMAÍ"), an EU-GMP European pharmaceutical and biotech company distributing cannabinoid-containing pharmaceuticals globally, today announced it has entered into a definitive agreement with AKANDA Corp.